keyboard_arrow_up

Mice Model Market (Oncology, Immunology, CNS) worth $1,819.9 Million by 2018

This report studies “Mice Model Market - By Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018”The market is estimated at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018.

Do Inquiry Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1308

Animal models have been used since the early days of scientific discovery and still contribute greatly towards understanding complex living systems and diseases. Mice models are the most commonly used animal models that have several benefits over other animal models, including the fact that the genetic makeup of mice is about 95% similar to that of humans.

Ask for Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=1308

The mice model market is marked by three major players contributing to approximately 75% of the mice model and services market. These players include The Jackson Laboratory (U.S.), Charles River Laboratories (U.S.), and Taconic Farms, Inc. (U.S.). The Jackson Laboratory—with its competitive pricing and huge inventory of mice models—accounts for the largest volume of mice sold to end users (approximately 3 million in 2012). However, the Charles River Laboratories is the leader in the mice model and services market as it is a for-profit distributor identity, which is in contrast to the non-profit distributor identity of The Jackson Laboratory. The for-profit status of Charles River enables sales of mice models and services at higher prices with significant restriction of mice breeding. Additional rights on breeding and/or cross-breeding are granted with a significantly higher fee, thus further increasing the company’s revenue. However, Jackson Laboratory is also a strong player in the market due to various factors, including its significantly large portfolio of over 2,500 targeted and 1,200 transgenic mutant mouse lines, high focus on in-house innovative mice model development increasing the intellectual property, and the large number of grants received that support the development of its mice model business. In addition, the company also has a strong brand presence with its JAX mice strains. In May 2013, Jackson entered into a cooperative agreement with Charles River Laboratories to provide its JAX mice strains and research services to biomedical researchers in 23 European and Asian countries.

Request for Free 10% Customization of Report@ http://www.marketsandmarkets.com/requestCustomization.asp?id=1308

These three players and other mice model companies follow various key growth strategies, such as agreements, partnerships, collaborations, and joint ventures; licensing; grants and funds; and patents, marketing and promotional activities, new product launches and others. In terms of strategies and tactical moves, Jackson Laboratory has been the most aggressive and competent firm in the past three years. The firm has made 17 strategic developments (2010 to 2013) to fortify its foothold in the global mice model market.

The major players in the mice model market include Charles River Laboratories (U.S.), The Jackson Laboratory (U.S.), Taconic farms, Inc. (U.S.), genOway S.A. (France), Covance, Inc. (U.S.), Crescendo Biologics Limited (U.K.), Deltagen, Inc. (U.S.), Harbour Antibodies BV (The Netherlands), Harlan Laboratories, Inc. (U.S.), TransGenic, Inc. (U.S.), SAGE Labs (U.S.), inGenious Targeting Laboratory, Inc. (U.S.), Lexicon Pharmaceuticals, ImmunoGenes AG (Switzerland), Mirimus, Inc. (U.S.), and Ablexis LLC (U.S.).

Browse Related Reports:

Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018
http://www.marketsandmarkets.com/Market-Reports/cancer-tumor-profiling-market-1250.html

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html
About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets